STOCK TITAN

SRX Global (SRXH) closes EMJX acquisition, issues new shares and adopts AI strategy

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

SRx Health Solutions, Inc. has closed its previously announced share exchange transaction with EMJ Crypto Technologies Inc. and CCC Crypto Corp., acquiring 100% of their equity interests and a 100% ownership interest in the defined IP Asset. At closing, the company issued an aggregate 268,346,659 shares of common stock, 117,268,196 exchangeable shares of ExchangeCo (on a one-for-one basis into common stock), and pre-funded warrants to purchase 44,368,530 shares of common stock, all registered on an effective Form S-4.

Immediately after closing, the company changed its legal name from SRx Health Solutions, Inc. to SRX Global Inc., while its stock continues to trade on the NYSE American under the ticker SRXH and will use the existing name for up to 10 business days. A related press release describes the launch of an AI-driven capital allocation platform centered on investments in high-conviction operating companies and assets.

Positive

  • None.

Negative

  • None.

Insights

SRX completes EMJX deal, issues large equity block and rebrands as SRX Global.

SRX Global has closed the EMJX/CCC Crypto transaction, acquiring 100% of both entities and related IP assets. Considerable equity was issued: 268,346,659 common shares, 117,268,196 exchangeable shares, and pre-funded warrants for 44,368,530 shares, all covered by an effective Form S-4.

The transaction shifts the business toward an AI-driven capital allocation and digital-asset treasury platform, using EMJX’s algorithms across digital and traditional assets. Management now highlights a focus on “high-conviction” investments and growth of the Halo consumer brands under the SRX Global umbrella.

The name and brand change to SRX Global Inc. signals this strategic repositioning, while the ticker SRXH remains on NYSE American. Future filings will be important for understanding how the new strategy translates into revenue, earnings, and returns relative to the sizable new share base.

Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Common stock issued at closing 268,346,659 shares Consideration in EMJX/CCC Crypto transaction
Exchangeable shares issued 117,268,196 shares ExchangeCo shares, 1:1 into common stock
Pre-funded warrant shares 44,368,530 shares Common stock underlying pre-funded warrants
Form S-4 file number 333-295154 Registration of issued and issuable securities
S-4 effectiveness date May 7, 2026 SEC declared Form S-4 effective
Press release date June 18, 2026 Announcement of closing and name change
Post-closing company name SRX Global Inc. New legal name after transaction
Ticker symbol SRXH Continues on NYSE American after name change
Share Exchange and Asset Transfer Agreement regulatory
"pursuant to the previously announced Share Exchange and Asset Transfer Agreement, dated December 16, 2025"
Exchangeable Shares financial
"117,268,196 exchangeable shares of ExchangeCo (the “Exchangeable Shares”) which are exchangeable for shares of Common Stock"
Exchangeable shares are stock-like securities that the holder can swap for shares of a different company or a different class of shares, usually according to a preset ratio and time conditions. Think of them like a coupon that can be redeemed for another product: their value and future supply depend on the underlying shares they convert into, so investors care because conversion can change ownership stakes, affect share supply and price, and shift potential returns or voting power.
Pre-Funded Warrants financial
"warrants (the “Pre-Funded Warrants”) to purchase 44,368,530 shares of Common Stock"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Regulation FD Disclosure regulatory
"Item 7.01. Regulation FD Disclosure. Closing of Share Exchange Transaction"
Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.
digital-asset treasury financial
"EMJX is a “Gen2” digital-asset treasury that now operates under the SRX Global platform"
A digital-asset treasury is a company’s reserve of cryptocurrencies, tokens, or other blockchain-based holdings kept alongside cash and securities on its balance sheet. Investors care because these holdings can act like a high-risk cash reserve—potentially boosting returns if prices rise but adding extra price swings, liquidity constraints, and regulatory uncertainty; think of it like a firm keeping some of its savings in a volatile foreign currency or commodity instead of just bank deposits.
forward-looking statements regulatory
"This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995."
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001471727 0001471727 2026-06-18 2026-06-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): June 18, 2026

 

 

 

SRx Health Solutions, Inc.

(Exact name of Registrant as Specified in its Charter)

 

 

 

Delaware   001-40477   83-4284557

(State or other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

12400 Race Track Road

Tampa, Florida 33626

(Address of Principal Executive Offices) (Zip Code)

 

 

 

(Registrant’s Telephone Number, Including Area Code): (212) 896-1254

 

N/A

(Former name or former address, if changed since last report.)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value share   SRXH   NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

  

 

 

Item 7.01. Regulation FD Disclosure.

 

Closing of Share Exchange Transaction

 

On June 18, 2026, SRx Health Solutions, Inc. (NYSE: SRXH) (the “Company”) issued a press release (the “Press Release”) announcing that it has completed the transaction (the “Transaction”) with EMJ Crypto Technologies Inc., a corporation organized under the laws of Ontario, Canada (“EMJC”), pursuant to the previously announced Share Exchange and Asset Transfer Agreement, dated December 16, 2025, and amended on March 11, 2026 and June 17, 2026 (as amended, the “Transfer Agreement”), by and among the Company, EMJC, CCC Crypto Corp., a Delaware corporation (“CCC Crypto”), 1001440571 Ontario Inc., a corporation organized under the laws of Ontario, Canada and an indirect wholly-owned subsidiary of the Company (“ExchangeCo”), and the other parties thereto. A copy of the Press Release is furnished as Exhibit 99.1 and incorporated herein by reference.

 

At the closing of the Transaction (the “Closing”), the Company acquired 100% of the issued and outstanding equity interests of each of EMJC and CCC Crypto, and a 100% direct and indirect ownership interest in the IP Asset, as such term is defined the Transfer Agreement, and the Company issued to EMJC and certain other parties to the Transaction an aggregate of (i) 268,346,659 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), (ii) 117,268,196 exchangeable shares of ExchangeCo (the “Exchangeable Shares”) which are exchangeable for shares of Common Stock on a one-for-one basis, and (iii) warrants (the “Pre-Funded Warrants”) to purchase 44,368,530 shares of Common Stock. The shares of Common Stock issued at the Closing, and the shares of Common Stock issuable upon the exchange or exercise of the Exchangeable Shares and Pre-Funded Warrants issued at the Closing, have been registered under the Securities Act of 1933, as amended (the “Securities Act”) in a Registration Statement on Form S-4 (File No. 333-295154) declared effective by the Securities and Exchange Commission (“SEC”) on May 7, 2026.

 

Name Change

 

The Press Release further announced that the Company had, immediately following the Closing, changed its legal name from “SRx Health Solutions, Inc.” to “SRX Global Inc.” The Company’s stock will remain trading on the NYSE under the ticker symbol “SRXH” and will continue to trade under the existing name for the 10 business days following the date of the Press Release.

 

The Press Release is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibits   Description
99.1   Press Release, dated June 18, 2026.
104   Cover Page Interactive Data File (Embedded within the Inline XBRL document)

 

  

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

June 18, 2026 SRx Health Solutions, Inc.
   
  By: /s/ Carolina Martinez
  Name: Carolina Martinez
  Title: Chief Financial Officer

 

  

 

 

Exhibit 99.1

 

 

SRx Health Solutions Closes EMJX Acquisition and Launches AI-Driven Platform Strategy Under New Name and Brand, SRX Global, Focused on Investments in High-Conviction Operating Companies and Assets

 

Company announces name change to SRX Global in conjunction with transaction closing

 

Company’s stock to remain trading on the NYSE American (“NYSE”) under ticker symbol “SRXH”

 

NORTH PALM BEACH, FL — June 18, 2026 — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”, or “SRX”) today announced it has completed the acquisition of EMJ Crypto Technologies, Inc. (“EMJX”) and is launching its new AI-driven platform strategy, which will focus on driving returns for shareholders through the allocation of capital into high-conviction operating companies and assets.

 

In conjunction with the transaction closing, the Company has changed its legal name and branding to SRX Global Inc. The Company’s stock will remain trading on the NYSE under the ticker symbol “SRXH” and will continue to trade under the existing name for up to 10 business days.

 

EMJX is a “Gen2” digital-asset treasury that now operates under the SRX Global platform, along with its Halo consumer brands. EMJX is structured as a multi-asset digital holdings platform that governs how capital is allocated, hedged, and reinvested across market cycles, rather than functioning as a passive balance sheet tracking asset values.

 

The combination of the two companies brings a highly experienced, operationally-focused team with deep public markets expertise together with next-generation, AI-enabled capital deployment strategies across digital and traditional assets, powered by proprietary algorithms developed by EMJX’s founder Eric Jackson. The Company has already made investments in areas it considers to be high-potential growth drivers, in companies such as Astro Capital, Opendoor Technologies Inc., Uber Technologies and Optimi Health Corp.

 

“The closing of the transaction with EMJX marks the start of a pivotal new era of opportunity and innovation for SRX Global,” said Kent Cunningham, CEO of SRX Global. “In addition to growing our Halo® business, we will be pursuing strategic actions centered on capital allocation driven by AI-enabled analytics towards high-growth assets and opportunistic investments. We believe there are significant synergies between SRX and EMJX and we intend to capitalize on these in as many ways possible to maximize shareholder value.”

 

“Most digital-asset treasuries ride up and down with the price of bitcoin,” commented Eric M. Jackson, Founder of EMJX and President, EMJX & Head of Asset Management of SRX Global. “EMJX is built to compound through the chop, not just ride the cycle. We’ve already deployed capital into multiple high-conviction positions through this transaction, and we’re bringing the same disciplined, AI-driven allocation framework that defined EMJX to SRX Global’s shareholders going forward.”

 

  

 

 

 

The management team of the newly merged company will comprise Kent Cunningham as Chief Executive Officer, Eric Jackson, PhD, as President, EMJX & Head of Asset Management, and Nina Martinez as Chief Financial Officer.

 

In conjunction with the Company’s name change and brand, a new website has been launched which can be found by visiting www.srxglobalinc.com.

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “expect,” “intend,” “aim,” “plan,” “may,” “could,” “target,” and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.

 

Company Contact

 

SRX Global

Kent Cunningham, Chief Executive Officer

 

Investor Relations Contact

 

KCSA Strategic Communications

Valter Pinto, Managing Director

212-896-1254

srx@kcsa.com

 

  

 

FAQ

What transaction did SRXH complete with EMJ Crypto Technologies Inc.?

SRX Global completed a share exchange transaction acquiring 100% of EMJ Crypto Technologies Inc. and CCC Crypto Corp. The deal also transferred full ownership of a defined IP Asset into SRX Global’s structure.

How many new shares and warrants did SRX Global issue in the EMJX deal?

SRX Global issued 268,346,659 common shares, 117,268,196 exchangeable shares of ExchangeCo, and pre-funded warrants to purchase 44,368,530 common shares. All of these securities were registered on an effective Form S-4.

Did SRXH change its company name after the EMJX acquisition?

Yes. Immediately following the EMJX transaction closing, the company changed its legal name from SRx Health Solutions, Inc. to SRX Global Inc. This rebranding aligns with its new AI-driven investment platform strategy.

Will SRX Global’s ticker symbol change after the name change?

The company’s stock will continue to trade on the NYSE American under the ticker symbol SRXH. It will trade under the existing SRx Health Solutions name for up to 10 business days following the press release date.

What strategic focus did SRX Global highlight after closing the EMJX acquisition?

SRX Global highlighted an AI-driven platform strategy focused on allocating capital into high-conviction operating companies and assets. Management emphasized using EMJX’s proprietary algorithms across digital and traditional assets and continuing to grow the Halo consumer brands.

Under which SEC registration were the new SRX Global securities issued?

The common shares, exchangeable shares, and pre-funded warrants issued at closing, plus the common stock issuable from them, were registered under the Securities Act on Form S-4, which the SEC declared effective on May 7, 2026.

Filing Exhibits & Attachments

5 documents